RSNA: Merge releases new toolkit

TriMed Staff | | Health Imaging | Artificial Intelligence
Merge Healthcare, a health IT developer, released its MergeCOM-3 DICOM Toolkit at the 96th annual scientific meeting of the Radiological Society of North America (RSNA) in Chicago, Nov. 28 to Dec. 3.

The MergeCOM-3 HL7 Toolkit adds a plug-in and sample for creating HL7 mappings through a graphical interface; allowing interface analysts to create and validate HL7 connectivity. The Milwaukee-based company added that its latest version of Merge’s Image Enhancement Toolkit enables digital radiography vendors to improve image quality and acquisition workflow for their next generation systems.

TriMed Staff

Related Content

New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
New algorithm is twice as accurate at predicting stroke timing compared to the standard of care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.